Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Recent developments include dual-targeted liposomes, which employ two different ligands to recognize multiple tumor-specific receptors, thereby enhancing targeting accuracy in complex tumor microenvironments
FDA is statutorily mandated to create these lists and issued a Proposed Rule on March 20, 2024, with comments being due by June 18, 2024
Clinicians say its an administrative challenge because insurers have inconsistent coverage criteria, require time-intensive documentation, and frequently deny coverage
the protocol scales by adding pulses, not by enlarging a single injection
US$ 23.28
US$ 21.40
US$ 28.08
US$ 21.58
US$ 29.30
US$ 28.66
US$ 29.73
US$ 22.33
US$ 25.96
